155 related articles for article (PubMed ID: 8894620)
1. Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells.
Ishizuka T; Suzuki K; Kawakami M; Hidaka T; Matsuki Y; Nakamura H
Eur J Pharmacol; 1996 Oct; 312(3):367-77. PubMed ID: 8894620
[TBL] [Abstract][Full Text] [Related]
2. DP-1904, a specific inhibitor of thromboxane A2 synthesizing enzyme, suppresses ICAM-1 expression by stimulated vascular endothelial cells.
Ishizuka T; Suzuki K; Kawakami M; Kawaguchi Y; Hidaka T; Matsuki Y; Nakamura H
Eur J Pharmacol; 1994 Sep; 262(1-2):113-23. PubMed ID: 7813562
[TBL] [Abstract][Full Text] [Related]
3. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2 (TXA2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells.
Ishizuka T; Sawada S; Sugama K; Kurita A
Clin Exp Immunol; 2000 Apr; 120(1):71-8. PubMed ID: 10759766
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
6. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig.
Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
Eur J Pharmacol; 1989 Feb; 160(3):313-21. PubMed ID: 2523812
[TBL] [Abstract][Full Text] [Related]
8. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
Okwu AK; Mais DE; Halushka PV
Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
[TBL] [Abstract][Full Text] [Related]
9. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis.
Cayatte AJ; Du Y; Oliver-Krasinski J; Lavielle G; Verbeuren TJ; Cohen RA
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1724-8. PubMed ID: 10894809
[TBL] [Abstract][Full Text] [Related]
10. Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells.
Petri MH; Tellier C; Michiels C; Ellertsen I; Dogné JM; Bäck M
Biochem Biophys Res Commun; 2013 Nov; 441(2):393-8. PubMed ID: 24161392
[TBL] [Abstract][Full Text] [Related]
11. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
Pfister SL; Pratt PE; Kurian J; Campbell WB
Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
13. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
14. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
15. Low-affinity thromboxane receptor mediates proliferation in cultured vascular smooth muscle cells of rats.
Ko FN
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1274-82. PubMed ID: 9261257
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2 and vascular smooth muscle cell proliferation.
Sachinidis A; Flesch M; Ko Y; Schrör K; Böhm M; Düsing R; Vetter H
Hypertension; 1995 Nov; 26(5):771-80. PubMed ID: 7591017
[TBL] [Abstract][Full Text] [Related]
17. Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells.
Ishizuka T; Kawakami M; Hidaka T; Matsuki Y; Takamizawa M; Suzuki K; Kurita A; Nakamura H
Clin Exp Immunol; 1998 Jun; 112(3):464-70. PubMed ID: 9649216
[TBL] [Abstract][Full Text] [Related]
18. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
Spurney RF; Middleton JP; Raymond JR; Coffman TM
Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
